Fangchinoline suppresses conjunctival melanoma by directly binding FUBP2 and inhibiting the homologous recombination pathway
Abstract Conjunctival melanoma (CM) is a rare and fatal ocular tumour with poor prognosis. There is an urgent need of effective therapeutic drugs against CM. Here, we reported the discovery of a novel potential therapeutic target for CM. Through phenotypic screening of our in-house library, fangchin...
Main Authors: | Keting Bao, Yongyun Li, Jinlian Wei, Ruoxi Li, Jie Yang, Jiahao Shi, Baoli Li, Jin Zhu, Fei Mao, Renbing Jia, Jian Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-03653-4 |
Similar Items
-
Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives
by: Yazhou Liu, et al.
Published: (2017-11-01) -
Uveal melanoma: progress in molecular biology and therapeutics
by: Yongyun Li, et al.
Published: (2020-10-01) -
Targeting FUBP1 in Hepatocellular Carcinoma
by: Khageh Hosseini, Sabrina
Published: (2014) -
Fangchinoline supplementation attenuates inflammatory markers in experimental rheumatoid arthritis-induced rats
by: Lu Shan, et al.
Published: (2019-03-01) -
Fangchinoline Induces Apoptosis, Autophagy and Energetic Impairment in Bladder Cancer
by: Bo Fan, et al.
Published: (2017-10-01)